The company launched T-Detect Lyme test which detects an immune response by using the body’s unique T-cell response to disease-associated Ags for early LD in adult patients & helps to reduce the time required for an accurate diagnosis
The T-Detect Lyme showed greater sensitivity than serology. In a clinical validation study, the T-cell test was more accurate than leading Ab tests with a specificity of ~99% & 1.5+ times greater sensitivity than STTT in patients with a bullseye rash (54% vs 30%) while in a separate study, 3 times greater sensitivity than STTT in the first 4 days after symptoms appeared (44% vs 14%)
T-Detect Lyme will aid in scaling clinical operations to support the T-Detect portfolio including testing for autoimmune disorders
Ref: GlobalNewswire | Image: Adaptive
